Drug Remdesivir finds a Corona weak spot, opens the door to treatments | ep 458

A double-blinded placebo-controlled randomised trial of Remdesivir's effectiveness on treating Covid-19 has shown it could reduce the fatality rate by 31%. This is not 100%, but it shows a way forward. In episode 458 of #CutTheClutter, Shekhar Gupta explains why Remdesivir's success is critical.